Method for the purification of antibodies

Patent metadata

Field	Value
Publication number	US-9631007-B2
Application number	US-201414271058-A
Country	US
Kind code	B2
Filing date	May 6, 2014
Priority date	May 25, 2005
Publication date	Apr 25, 2017
Grant date	Apr 25, 2017

Abstract

A method for the purification of immunoglobulins by ion exchange chromatography is described. The chromatographic method uses a weak ion exchange resin and a single step elution process for the purification of an immunoglobulin. Additionally a method for the determination of the salt concentration for the single step elution of an immunoglobulin from an ion exchange resin is described.

First claim

We claim:

1. A method for purifying a monomeric monoclonal antibody from aggregates thereof, wherein the method comprises:
a) purifying a monoclonal antibody by protein A affinity chromatography to provide a solution comprising the monomeric monoclonal antibody and aggregates thereof;
b) adjusting pH of the solution comprising the monoclonal antibody and aggregates thereof from step a) to below isoelectric point (pI) of the monoclonal antibody;
c) bringing the pH adjusted solution from step b) and a weak cation exchange material in contact under conditions whereby the monoclonal antibody binds to the weak cation exchange material; and
d) recovering the monomeric monoclonal antibody from the weak cation exchange material in a single step by a second solution comprising a buffer substance and a salt wherein the conductivity of the second solution is increased by changing one condition all at once from a starting value to a final value which results in purification of the monomeric monoclonal antibody from aggregates thereof.

2. The method according to claim 1 , wherein the buffer substance of step d) is selected from the group consisting of citric acid, a salt of citric acid, phosphoric acid, and a salt of phosphoric acid.

3. The method according to claim 2 , wherein the method is chromatographic or a batch method.

4. The method according to claim 3 , wherein the monoclonal antibody has a pI of 6.0 or higher.

5. The method according to claim 2 , wherein the pH is kept constant in the single step.

6. The method according to claim 5 , wherein the monoclonal antibody has a pI of 6.0 or higher.

7. The method according to claim 2 , wherein the monoclonal antibody has a pI of 6.0 or higher.

8. The method according to claim 1 , wherein the method is a chromatographic or a batch method.

9. The method according to claim 8 , wherein the pH is kept constant in the single step.

10. The method according to claim 9 , wherein the monoclonal antibody has a pI of 6.0 or higher.

11. The method according to claim 8 , wherein the monoclonal antibody has a pI of 6.0 or higher.

12. The method according to claim 1 , wherein the salt of step d) is selected from the group consisting of sodium chloride, sodium sulphate, potassium chloride, potassium sulfate, salts of citric acid, salts of phosphoric acid, and mixtures thereof.

13. The method according to claim 12 , wherein the monoclonal antibody has a pI of 6.0 or higher.

14. The method according to claim 1 , wherein the pH is kept constant in the single step.

15. The method according to claim 14 , wherein the monoclonal antibody has a pI of 6.0 or higher.

16. The method according to claim 1 , wherein the monoclonal antibody has pI of 6.0 or higher.

17. The method according to claim 1 , wherein the salt in elution step d) is added at the same time as the buffer substance.

18. The method according to claim 1 , wherein the weak cation exchange material is a carboxy-methyl weak cation exchange material.

19. The method according to claim 1 , wherein the monoclonal antibody is a member of the immunoglobulin class G.

20. The method according to claim 1 , wherein the second solution in the recovery step d) has a pH value of from pH 3.0 to pH 7.0.

Assignees

• Hoffmann La Roche
• Hoffmann-La-Roche Inc

Inventors

• Falkenstein Roberto
• Kolb Burkard
• Sebald Maria

Classifications

• G01N30/96

  using ion-exchange (G01N30/02, G01N30/90 take precedence) · CPC title

• B01D15/363

  Anion-exchange · CPC title

• B01D15/426

  Specific type of solvent · CPC title

• C07K2317/50

  characterized by immunoglobulin fragments · CPC title

• C07K16/32

  against translation products of oncogenes · CPC title